OakChart

AdaptHealth Corp

AHCOHealthcare·Medical Devices·USA·Small·NASD·Nov 11 • 3:59 PM ET

7.80+0.08 (1.04%)
2026-11-12 05:40 CET
Market cap
1,064.89 USD m
Revenue, TTM
3,152.04 USD m
Net income, TTM
-404.04 USD m
Free cash flow, TTM
81.92 USD m
EPS diluted, TTM
-2.97
P/E
-
Compare

Price

AHCO against its 20, 50 and 200-day averages
2050200miss
6.008.0010.0012.009.5M19.0MVolumeMay 26Jun 26Jul 26Aug 26Sep 26Oct 26Nov 26AHCOclose 7.8020-day 6.4750-day 6.12200-day 9.067.8052w low

41.9% under the 52-week high of 13.43 on 4 May 2026. 52-week low 5.21 on 10 Aug 2026. Last 15 sessions, 40.3% high to low

Volume 0.83× normal · the line is the 50-bar volume average

Profile

AHCO
52-week range, 32% of the way up
5.2113.43

AdaptHealth Corp. engages in the provision of home healthcare equipment, supplies and related services. It focuses on sleep therapy equipment to individuals suffering from obstructive sleep apnea (OSA), home medical equipment to patients discharged from acute care and other facilities, oxygen and related chronic therapy services in the home, and HME medical devices and supplies on behalf of chronically ill patients with diabetes care, wound care, urological, ostomy, and nutritional supply needs. The company was founded in 2012 and is headquartered in Conshohocken, PA.

IndexRUT
Employees10900
IPOMay 24, 2018
Beta1.27
ATR, 14d0.37
Rel volume0.83
Short float12.64%
Insider own36.66%
Inst own73.04%

Snapshot

6 groups

Valuation

IndexRUT
Market Cap1.06B
Enterprise Value3.04B
Income-404.04M
Sales3.15B
Book/sh9.18
Cash/sh0.59
Dividend Est.-
Dividend TTM-
Dividend Ex-Date-
Dividend Gr. 3/5Y- -
Payout-
Employees10900
IPOMay 24, 2018

Ratios

P/E-
Forward P/E-
PEG-
P/S0.34
P/B0.85
P/C13.20
P/FCF13.00
EV/EBITDA5.19
EV/Sales0.96
Quick Ratio0.98
Current Ratio1.13
Debt/Eq1.67
LT Debt/Eq1.61
Option/ShortYes / Yes

Earnings

EPS (ttm)-2.97
EPS next Y-0.05
EPS next Q-0.04
EPS this Y-125.86%
EPS next Y71.71%
EPS next 5Y-
EPS past 3/5Y- 29.83%
Sales past 3/5Y2.99% 25.16%
EPS Y/Y TTM-636.28%
Sales Y/Y TTM-3.17%
EPS Q/Q-790.10%
Sales Q/Q-9.10%
EarningsNov 03 BMO
EPS/Sales Surpr.664.75% 2.73%

Ownership

Insider Own36.66%
Insider Trans0.08%
Inst Own73.04%
Inst Trans-4.64%
ROA-10.01%
ROE-30.23%
ROIC-12.61%
Gross Margin14.85%
Oper. Margin3.24%
Profit Margin-12.82%
SMA2020.61%
SMA5027.42%
SMA200-13.91%
Trades-

Technical

Shs Outstand133.53M
Shs Float86.47M
Short Float12.64%
Short Ratio4.06
Short Interest10.93M
52W High13.43 -41.92%
52W Low5.21 49.71%
Volatility5.48% 5.77%
ATR (14)0.37
RSI (14)76.41
Beta1.27
Rel Volume0.83
Avg Volume2.69M
Volume2,237,695

Performance

Perf Week6.70%
Perf Month23.22%
Perf Quarter36.84%
Perf Half Y-27.84%
Perf YTD-21.69%
Perf Year-18.24%
Perf 3Y13.37%
Perf 5Y-68.80%
Perf 10Y-
Recom1.14
Target Price8.86
Prev Close7.72
Price7.80
Change %1.04%

Analyst ratings

latest 10 of 18
DateActionAnalystRating changeTargetImplied
Jan 08, 2024DowngradeJJefferiesBuy → Hold$14.50 → $8+2.6%
Nov 08, 2023DowngradeBBofA SecuritiesNeutral → Underperform$9.50 → $6.50-16.7%
May 10, 2023DowngradeSStifelBuy → Hold$18 → $11+41.0%
May 10, 2023DowngradeDDeutsche BankBuy → Hold$28 → $11.30+44.9%
May 09, 2023DowngradeBBofA SecuritiesBuy → Neutral$21 → $12+53.8%
Sep 27, 2021InitiatedSSVB LeerinkOutperform$30+284.6%
Jul 14, 2021UpgradeRRobert W. BairdNeutral → Outperform$30 → $36+361.5%
Apr 13, 2021DowngradeRRobert W. BairdOutperform → Neutral
Mar 18, 2021InitiatedTTruistBuy
Jan 26, 2021InitiatedBBofA SecuritiesBuy$46+489.7%

Peers

Mkt cap
TickerCompanyMkt cap
VMDViemed Healthcare Inc345.96M
INGNInogen Inc149.51M
OPCHOption Care Health Inc4.75B
RMDResmed Inc33.55B
DXCMDexcom Inc29.96B
AVAHAveanna Healthcare Holdings Inc2.86B
BTSGBrightSpring Health Services Inc14.45B
ADUSAddus HomeCare Corp2.34B
PNTGPennant Group Inc1.29B
EMBCEmbecta Corp369.99M

Insider trading

latest 14 of 19
InsiderRelationshipDateTransactionCostSharesValueTotal heldForm
JASON A CLEMENSFormer CFONov 06 '26Proposed Sale7.3460,978447,510Nov 06 04:17 PM
JASON A CLEMENSFormer CFONov 05 '26Proposed Sale7.43169,7791,260,743Nov 05 04:13 PM
SAMET KENNETH ADirectorAug 06 '26Buy6.3823,500149,93048,569Aug 10 08:03 PM
WOLF DALE BDirectorAug 06 '26Buy6.3720,000127,400143,234Aug 10 08:02 PM
WOLF DALE BDirectorAug 07 '26Buy5.8620,000117,20034,000Aug 10 08:02 PM
Schuster III Russell E.Chief Commercial OfficerJul 01 '26Sale10.4411,275117,711125,263Jul 06 04:01 PM
Schuster III Russell E.OfficerJul 01 '26Proposed Sale10.4411,275117,711Jul 01 11:51 AM
Schuster III Russell E.Chief Commercial OfficerJun 01 '26Sale10.0611,275113,426136,538Jun 03 06:43 PM
Schuster III Russell E.OfficerJun 01 '26Proposed Sale10.0611,275113,426Jun 01 12:38 PM
CASHIN RICHARD M JR10% OwnerMar 20 '26Buy9.91447,1004,431,70016,312,698Mar 23 06:25 PM
CASHIN RICHARD M JR10% OwnerMar 19 '26Buy9.947277,22815,865,598Mar 23 06:25 PM
Prast Albert A.Chief Technology OfficerMar 13 '26Option Exercise4.3889,451391,795532,358Mar 16 04:04 PM
CASHIN RICHARD M JR10% OwnerMar 10 '26Buy9.73820,5287,982,67114,638,708Mar 12 09:11 PM
CASHIN RICHARD M JR10% OwnerMar 12 '26Buy9.73689,3366,707,17015,864,871Mar 12 09:11 PM

Held by

AUM
TickerCompanyAUM
IJRiShares Core S&P Small-Cap ETFAUM: 106.27B
IWMiShares Russell 2000 Index FundAUM: 77.38B
VTIVanguard Morningstar Total Stock Market ETFAUM: 687.42B
DFSVUS Small Cap Value Portfolio ETF Class SharesAUM: 8.52B
DFATU.S. Targeted Value Portfolio-ETF Class SharesAUM: 14.47B
SPSMState Street SPDR Portfolio S&P 600TM Small Cap ETFAUM: 16.06B
IWNiShares Russell 2000 Value ETFAUM: 14.10B
VBVanguard Morningstar Small-Cap ETFAUM: 79.59B
IJSiShares S&P Small-Cap 600 Value ETFAUM: 7.74B
VXFVanguard Extended Market Index ETFAUM: 30.47B

News

latest 14 of 198

Quarterly earnings

actual against estimate
PeriodReportedEPS actEPS estEPS repSales actSales estAnalysts
2026Q32026-11-030.285-0.051-1.130745.65725.877
2026Q22026-08-040.1600.169-0.984740.31846.777
2026Q12026-05-05-0.0560.013-0.118819.8796.638
2025Q42026-02-240.2250.351-0.739846.29831.618
2025Q32025-11-040.2370.2410.164820.31799.318
2025Q22025-08-050.2180.1580.098800.37803.87
2025Q12025-05-060.0270.047-0.054777.88764.776
2024Q42025-02-250.4270.2820.337856.65829.198
2024Q32024-11-050.2240.1910.153805.86809.327
2024Q22024-08-060.2170.1920.131805.98802.628
2024Q12024-05-070.0930.061-0.016792.5769.879
2023Q42024-02-270.5560.193-1.914858.23825.4510
2023Q32023-11-070.4150.198-3.368804.03796.69
2023Q22023-08-080.2280.1320.094793.29765.179
2023Q12023-05-090.0510.097-0.055744.63756.478
2022Q42023-02-270.0540.310-0.019780.28788.138

Annual earnings

PeriodEPS actEPS estEPS repSales actSales est
2019FY-0.6600.090-0.946529.64522.32
2020FY0.4730.579-3.0791,0561,031
2021FY1.6831.1741.1742,4552,439
2022FY0.7070.8650.4992,9712,978
2023FY1.3170.797-5.0613,2003,167
2024FY1.0620.9200.6113,2613,234
2025FY0.6190.690-0.5203,2453,230
2026FY--0.160--2,906
2027FY--0.045--2,990
2028FY-0.084--3,117
2029FY-0.420---
2030FY-0.590---

Estimate revisions

last 14 periods
PeriodTypeDateEstimatesUpDownMeanLowHigh
2026Q4S2026-11-04713720.02687.05731.3
2026Q4S2026-11-03713721.89687.05744.4
2026Q4S2026-10-20701711.41593.21744.4
2026Q4S2026-10-19702711.41593.21744.4
2026Q4S2026-10-18703711.41593.21744.4
2026Q4S2026-08-21707711.41593.21744.4
2026Q4S2026-08-10707716.04593.21758.3
2026Q4S2026-08-06707716.04593.21758.3
2026Q4S2026-08-05706745.61593.21951.4
2026Q4S2026-08-04705793.45715.1951.4
2026Q4S2026-07-21700933.03916.8951.4
2026Q4S2026-07-20701933.03916.8951.4
2026Q4S2026-07-19701932.98916.8951.4
2026Q4S2026-07-17704932.98916.8951.4

Estimate history

EPS, annual01.955-0.946-3.0791.1740.499-5.0610.611-0.524-2.9699
Period201720182019202020212022202320242025TTM
EPS, quarterly0.1530.337-0.0540.0980.164-0.739-0.118-0.984-1.129
PeriodQ3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26
Sales, annual0345.278529.6441056.3892454.5352970.5953200.1773260.9753244.8573152.04
Period201720182019202020212022202320242025TTM
Sales, quarterly805.858856.645777.882800.372820.314846.289819.799740.307745.648
PeriodQ3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26
Shares, annual31.2531.2540.81676.457133.844134.435132.635134.602135.45133.526
Period201720182019202020212022202320242025MRQ
Shares, quarterly131.604134.602132.006135.216135.424135.45136.013136.305133.526
PeriodQ3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26

Income statement, annual

Currency USD, millions
MetricTTM2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY
Total Revenue3,152.043,244.863,260.973,200.182,970.592,454.531,056.39529.64345.28
Cost of Goods Sold Incl. D&A2,683.972,676.302,624.932,777.702,618.062,069.99904.37442.92296.12
Gross Profit468.08568.56636.05422.48352.54384.54152.0286.7349.16
Selling, General and Administrative Excl. Other365.88361.39341.44182.03156.12116.0362.7839.0715.67
Other Operating Expense0.000.000.000.000.000.000.000.000.00
Operating Income102.19207.17294.61240.45196.41268.5189.2447.6633.49
Interest Expense104.84105.75127.07132.10109.4195.1941.4327.888.00
Unusual Expense484.67149.9041.27851.00-11.15-19.48254.5530.523.25
Net Income Before Taxes-467.95-15.15136.02-723.7897.90190.96-206.04-21.8622.24
Income Taxes-40.4150.8841.24-49.0024.7732.81-11.960.74-2.10
Consolidated Net Income-424.85-66.0487.11-674.7873.13158.15-194.09-22.6024.34
Net Income From Continuing Operations-429.68-70.7982.75-678.8969.32156.18-161.63-21.3423.26
Net Income-404.04-70.7982.75-678.8969.32156.18-161.63-21.3423.26
EPS (Recurring)-0.470.250.82-0.620.441.070.320.002.15
EPS (Basic, Before Extraordinaries)-2.97-0.520.62-5.060.521.24-3.08-0.951.95
EPS (Diluted)-2.97-0.520.61-5.060.501.17-3.08-0.951.95
EBITDA585.83635.55703.89661.04619.86601.68171.68110.2384.10
Non-Operating Income (Expense)19.3733.339.7418.87-0.25-1.830.70-11.130.00
Other After Tax Adjustments2.690.00-7.670.000.000.000.000.000.00
Stock Option Compensation Expense14.2517.2811.7617.7520.3020.7216.574.160.70
Price To Earnings Ratio----42.4959.54-106.47150.31
Price To Sales Ratio0.240.410.400.310.901.331.870.470.34
Gross Margin14.8517.5219.5013.2011.8715.6714.3916.3714.24
Operating Margin3.246.389.037.516.6110.948.459.009.70
Net Margin-12.82-2.182.54-21.212.336.36-15.30-4.036.74
Shares Outstanding133.53135.45134.60132.63134.44133.8476.4640.8231.25
Market Capitalization1,064.891,064.891,349.59994.282,589.553,233.982,699.20364.68307.19

Income statement, quarterly

Currency USD, millions
Metric2026Q32026Q22026Q12025Q42025Q32025Q22025Q12024Q4
Total Revenue745.65740.31819.80846.29820.31800.37777.88856.64
Cost of Goods Sold Incl. D&A640.16641.35718.40684.06668.47655.91667.86675.46
Gross Profit105.4998.96101.40162.23151.84144.46110.02181.19
Selling, General and Administrative Excl. Other83.7688.6294.5198.9985.9187.6484.5586.72
Other Operating Expense0.000.000.000.000.000.000.000.00
Operating Income21.7310.346.8963.2465.9356.8325.4794.47
Interest Expense28.6026.2125.5924.4425.3827.5328.4029.73
Unusual Expense189.65155.731.40137.904.209.803.500.67
Net Income Before Taxes-184.52-165.33-20.11-97.9936.3551.72-5.2370.71
Income Taxes-17.49-21.23-5.233.5410.6035.890.8519.31
Consolidated Net Income-167.03-144.11-14.87-98.8523.6914.59-6.0847.14
Net Income From Continuing Operations-168.25-145.32-16.04-100.0822.4513.44-7.2146.00
Net Income-153.99-133.93-16.04-100.0822.4513.44-7.2146.00
EPS (Recurring)-0.16-0.18-0.11-0.030.190.15-0.040.34
EPS (Basic, Before Extraordinaries)-1.13-0.98-0.12-0.740.170.10-0.050.34
EPS (Diluted)-1.13-0.98-0.12-0.740.160.10-0.050.34
EBITDA152.21136.11124.19173.31175.14160.72130.68196.12
Non-Operating Income (Expense)12.006.270.001.100.0032.231.206.64
Other After Tax Adjustments0.000.000.002.69-2.06-1.240.00-4.26
Stock Option Compensation Expense0.794.275.134.064.194.824.193.37
Price To Earnings Ratio---18.2717.7415.8318.82-
Price To Sales Ratio0.240.440.490.420.380.400.450.40
Gross Margin14.1513.3712.3719.1718.5118.0514.1421.15
Operating Margin2.911.400.847.478.047.103.2711.03
Net Margin-20.65-18.09-1.96-11.832.741.68-0.935.37
Shares Outstanding133.53136.31136.01135.45135.42135.22132.01134.60
Market Capitalization1,064.891,417.681,617.391,348.821,283.981,211.831,534.791,349.59

Balance sheet, annual

Currency USD, millions
Metric2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY
Cash & Short Term Investments106.14109.7577.1346.27149.6399.9676.8825.190.12
Short Term Receivables370.90408.02388.91359.15359.90171.0678.6253.020.00
Inventories151.25139.84113.64127.75123.0958.7813.247.670.00
Other Current Assets100.6298.1869.3452.1437.4433.4412.684.920.00
Total Current Assets728.90755.79649.02585.31670.06363.25181.4190.790.12
Net Property, Plant & Equipment674.22618.36637.53622.01546.34110.4763.5661.600.00
Total Investments and Advances0.000.130.990.000.000.000.000.000.00
Intangible Assets2,626.552,780.712,855.123,708.073,714.801,114.87266.79202.440.00
Deferred Tax Assets393.22405.28457.03415.41444.65211.4532.1912.86-
Other Assets19.1217.4520.1422.4115.1016.486.855.050.19
Total Assets4,442.014,577.724,619.835,353.225,390.941,816.52550.81372.740.31
Short Term Debt Incl. Current Port. of LT Debt68.7460.5191.7667.2166.8630.4321.4727.900.17
Accounts Payable352.38284.60211.50222.50248.03191.0479.2470.600.00
Income Tax Payable---4.304.304.300.00--
Other Current Liabilities291.27221.88233.74162.20180.62196.2953.3437.170.11
Total Current Liabilities712.39566.99537.00456.21499.81422.05154.05135.680.29
Long Term Debt1,834.062,069.832,202.892,261.612,303.73777.43395.11127.270.00
Provision for Risks Charges0.000.000.0038.5057.76113.9127.640.000.00
Deferred Tax Liabilities125.4390.78111.18137.93144.757.354.273.78-
Other Liabilities243.80272.02302.09301.20318.19214.9335.523.240.00
Total Liabilities2,915.682,999.603,153.163,195.463,324.251,535.68616.59269.970.29
Non-Equity Reserves0.000.000.000.000.000.000.000.000.00
Preferred Stock - Carrying Value0.000.000.000.000.000.000.000.000.00
Common Equity1,518.561,571.141,458.452,151.162,061.91354.89-38.8299.900.02
Total Shareholders Equity1,518.561,571.141,458.452,151.162,061.91354.89-38.8299.900.02
Accumulated Minority Interest7.766.978.216.604.78-74.04-26.962.870.00
Total Equity1,526.321,578.121,466.672,157.762,066.69280.85-65.78102.770.02
Total Liabilities & Stockholders Equity4,442.014,577.724,619.835,353.225,390.941,816.52550.81372.740.31
Book Value Per Share11.2111.6711.0016.0015.414.64-0.950.160.00
Tangible Book Value Per Share-8.18-8.99-10.53-11.58-12.35-9.94-7.490.160.00
Full-Time Employees10,90010,50010,70010,90010,7004,7002,59022
Price to Book Ratio0.850.870.561.201.598.091.1561.4461.44
Return on Assets-1.571.80-13.611.294.33-13.66-4.6212.47-
Return on Equity-4.585.46-37.623.2912.92-94.97-69.8746.55-
Return on Invested Capital-2.112.27-18.541.573.58-14.27-5.9910.24-2.85
Quick Ratio0.811.091.001.001.090.721.090.610.42
Current Ratio1.021.331.211.281.340.861.180.670.42

Cash flow, annual

Currency USD, millions
MetricTTM2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY
Net Income-401.89-66.0494.78-674.7873.13158.15-194.09-22.6024.34
Depreciation500.70428.38409.28420.59383.44286.6882.4462.5747.88
Other Funds (Non Cash)465.87125.6831.79822.567.25-38.22251.4736.8817.01
Funds from Operations531.24535.19567.90505.77481.86428.99118.7277.3286.35
Extraordinary Item0.000.000.000.000.000.000.000.000.00
Changes in Working Capital47.5566.58-26.06-25.11-108.00-153.3176.91-16.90-17.92
Income Taxes Payable--------0.16
Cash from Operating Activities578.80601.77541.84480.67373.87275.68195.6360.4268.43
Capital Expenditures-496.88-382.39-306.06-337.46-391.42-203.31-39.76-21.33-9.95
Net Assets From Acquisitions-151.24-42.38-9.54-19.69-19.02-1,620.32-769.34-63.54-86.33
Sale of Fixed Assets and Businesses10.95120.425.320.00-0.000.000.000.00
Purchase or Sale of Investments-2.000.000.00-0.13-0.73-1.12-6.610.000.00
Purchase of Investments-2.000.000.00-0.13-0.73-1.12-8.660.000.00
Sale Or Maturity of Investments0.000.000.000.000.000.002.050.000.00
Other Uses0.000.000.000.000.000.000.000.000.00
Other Sources0.001.160.000.000.000.000.000.000.00
Cash from Investing Activities-639.16-303.19-310.27-357.28-411.17-1,824.75-815.70-84.87-96.28
Cash Dividends Paid0.000.000.000.000.000.000.00-250.000.00
Change in Capital Stock1.341.211.74-26.66-9.87278.35380.47120.450.00
Repurchase of Common Pref Stock0.000.000.00-29.27-13.990.000.00-23.710.00
Sale of Common Pref Stock1.341.211.742.624.13278.35380.47144.160.00
Proceedsfrom Stock Options1.341.211.002.031.62266.03380.47144.160.00
Issuance or Reduction of Debt, Net95.30-268.48-186.29-51.77-36.181,366.38341.69176.6350.05
Change in Long Term Debt95.30-268.48-186.29-51.77-36.181,366.38341.69176.6350.05
Issuance of Long Term Debt894.560.00247.0550.000.002,235.82928.23451.47162.03
Reduction of Long Term Debt-799.25-268.48-433.34-101.77-36.18-869.43-586.53-274.84-111.99
Net Financing Active Other Cash Flow-35.94-34.92-14.40-14.10-20.01-45.99-79.0129.07-1.28
Other Financing Activities Uses-35.94-34.92-14.40-14.10-20.01-45.99-79.01-14.85-1.28
Cash from Financing Activities60.70-302.19-198.95-92.53-66.051,598.74643.1576.1448.77
Net Change in Cash0.33-3.6132.6230.86-103.3649.6623.0851.6920.91
Free Cash Flow81.92219.38235.78143.20-17.5672.37155.8839.0958.48
Preferred Dividends (Cash Flow)-------0.000.00
Price to Free Cash Flow9.396.145.476.84-44.9612.65-2.00
Deferred Taxes & Investment Tax Credit-47.1632.05-62.5918.0422.38-21.100.48-2.88

Balance sheet, quarterly

Currency USD, millions
Metric2026Q32026Q22026Q12025Q42025Q32025Q2
Cash & Short Term Investments80.6943.2947.96106.1480.3668.63
Short Term Receivables395.87390.39391.97370.90412.52393.59
Inventories111.90105.48159.27151.25149.09148.85
Other Current Assets250.64258.3288.28100.6282.8646.93
Total Current Assets839.09797.48687.48728.90724.82658.00
Net Property, Plant & Equipment807.50828.37795.08674.22628.56625.52
Total Investments and Advances0.000.000.000.000.000.00
Intangible Assets2,188.222,402.212,647.602,626.552,743.492,746.26
Deferred Tax Assets303.00290.72275.06393.22267.92302.24
Other Assets62.9022.0918.8019.1218.7218.81
Total Assets4,200.714,340.874,424.014,442.014,383.524,350.82
Short Term Debt Incl. Current Port. of LT Debt71.0763.4978.2768.7460.1459.69
Accounts Payable443.77389.52431.95352.38341.45339.65
Other Current Liabilities229.97256.20233.07291.27269.11222.74
Total Current Liabilities744.82709.21743.29712.39670.70622.09
Long Term Debt1,978.862,001.601,922.431,834.061,843.801,890.43
Provision for Risks Charges0.000.000.000.000.000.00
Deferred Tax Liabilities---125.43--
Other Liabilities243.81243.81243.81243.80244.17244.17
Total Liabilities2,967.482,954.612,909.532,915.682,758.672,756.70
Non-Equity Reserves0.000.000.000.000.000.00
Preferred Stock - Carrying Value0.000.000.000.000.000.00
Common Equity1,225.691,378.461,507.071,518.561,616.781,587.44
Total Shareholders Equity1,225.691,378.471,507.071,518.561,616.781,587.44
Accumulated Minority Interest7.547.797.417.768.076.68
Total Equity1,233.231,386.261,514.481,526.321,624.851,594.13
Total Liabilities & Stockholders Equity4,200.714,340.874,424.014,442.014,383.524,350.82
Book Value Per Share9.1810.1111.0811.2111.9411.74
Tangible Book Value Per Share-7.21-7.51-8.39-8.18-8.32-8.57
Full-Time Employees---10,900--
Price to Book Ratio0.850.941.060.830.810.76
Return on Assets-10.01-5.50-1.81-1.581.691.65
Return on Equity-30.23-16.12-5.22-4.624.774.76
Return on Invested Capital-4.81-3.96-0.47-2.990.650.39
Quick Ratio0.980.980.710.810.860.82
Current Ratio1.131.120.921.021.081.06

Cash flow, quarterly

Currency USD, millions
Metric2026Q32026Q22026Q12025Q42025Q32025Q2
Net Income-152.77-132.72-14.87-101.5425.7515.83
Depreciation132.48135.97122.17110.07109.21103.89
Other Funds (Non Cash)178.04146.477.62133.739.64-24.27
Funds from Operations145.47134.18109.32142.27179.12108.87
Extraordinary Item0.000.000.000.000.000.00
Changes in Working Capital11.1211.12-15.6040.92-18.0653.13
Cash from Operating Activities156.59145.3093.72183.18161.07161.99
Capital Expenditures-105.53-166.24-121.21-103.90-94.24-88.67
Net Assets From Acquisitions0.00-42.74-84.68-23.820.00-18.56
Sale of Fixed Assets and Businesses0.006.271.443.251.50115.67
Purchase or Sale of Investments-2.000.000.000.000.000.00
Purchase of Investments-2.000.000.000.000.000.00
Sale Or Maturity of Investments0.000.000.000.000.000.00
Other Uses0.000.000.000.000.000.00
Other Sources0.000.000.000.000.001.16
Cash from Investing Activities-107.53-202.71-204.46-124.47-92.749.60
Cash Dividends Paid0.000.000.000.000.000.00
Preferred Dividends (Cash Flow)0.00---0.00-
Change in Capital Stock0.390.490.460.000.650.00
Repurchase of Common Pref Stock0.000.000.000.000.000.00
Sale of Common Pref Stock0.390.490.460.000.650.00
Proceedsfrom Stock Options0.390.490.460.000.650.00
Issuance or Reduction of Debt, Net-10.2454.0182.83-31.30-53.83-155.12
Change in Long Term Debt-10.2454.0182.83-31.30-53.83-155.12
Issuance of Long Term Debt324.59469.96100.000.000.000.00
Reduction of Long Term Debt-334.84-415.95-17.17-31.30-53.83-155.12
Net Financing Active Other Cash Flow-1.81-1.76-30.73-1.64-3.41-1.49
Other Financing Activities Uses-1.81-1.76-30.73-1.64-3.41-1.49
Cash from Financing Activities-11.6752.7452.56-32.94-56.60-156.62
Net Change in Cash37.40-4.67-58.1725.7811.7314.98
Free Cash Flow51.06-20.94-27.4979.2966.8273.33
Price to Free Cash Flow9.3914.528.426.155.765.59

Revenue breakdown

Total Services-Home Health Care Services revenue2024: 3.26B 2025: 3.24B
United States2024: 3.26B 2025: 3.24B
Diabetes Health2024: 614.41M 2025: 592.41M
Respiratory Health2024: 651.15M 2025: 691.16M
Sleep Health2024: 1.35B 2025: 1.38B
Wellness at Home2024: 646.20M 2025: 583.14M

Short interest

shares short against float, oldest to newest
SettlementOf floatShares shortFloatAvg volume
2026-10-3012.64%10.9M86.5M3.12M
2026-10-1511.85%10.2M86.4M2.93M
2026-09-3011.11%9.6M86.4M2.77M
2026-09-1511.16%9.6M86.4M2.73M
2026-08-3112.03%10.4M86.4M2.41M
2026-08-148.80%7.6M86.4M2.19M
2026-07-319.33%8.1M86.5M1.41M
2026-07-159.29%8.0M86.3M1.46M
2026-06-309.34%8.1M86.3M1.47M
2026-06-158.61%7.4M86.4M1.38M
2026-05-298.72%7.5M86.4M1.48M
2026-05-158.32%7.2M86.4M1.57M
2026-04-309.23%8.0M86.3M1.41M
2026-04-159.30%8.0M86.1M1.35M
2026-03-319.40%8.3M88.5M1.31M
2026-03-1310.22%9.0M88.5M1.22M
2026-02-278.34%7.4M88.5M1.10M
2026-02-138.54%7.6M88.5M996.54K
2026-01-308.85%7.8M88.2M1.07M
2026-01-1510.60%9.4M89.1M1.06M

Option chain

expiry 2026-11-20
TypeStrikeBidAskLastIVOpen intVolumeDeltaThetaVega
call2.504.606.000.009.4470.000.000.980-0.0150.001
call5.002.153.502.804.5803.001.000.953-0.0130.001
call7.500.001.150.302.0931710.000.613-0.0580.005
call10.000.000.750.002.9650.000.000.380-0.0780.005
call12.500.000.750.003.9430.000.000.323-0.0970.004
put2.500.000.750.004.2750.000.00-0.020-0.0140.001
put5.000.000.750.051.87812.000.00-0.047-0.0130.001
put7.500.000.902.652.2162.000.00-0.387-0.0570.005
put10.001.552.850.002.7680.000.00-0.620-0.0770.005
put12.504.005.400.003.8560.000.00-0.677-0.0960.004

Latest SEC filings

30
FiledFormDescriptionPeriodLink
2026-11-06144Filing for proposed sale of securities under Rule 144.SEC
2026-11-05144Filing for proposed sale of securities under Rule 144.SEC
2026-11-05SCHEDULE 13G/ASEC
2026-11-0310-QQuarterly report pursuant to Section 13 or 15(d)2026-09-30SEC
2026-11-038-KCurrent report2026-11-03SEC
2026-10-13SCHEDULE 13G/ASEC
2026-10-08SCHEDULE 13G/ASEC
2026-09-114Statement of changes in beneficial ownership of securities2026-09-09SEC
2026-09-113Initial statement of beneficial ownership of securities2026-09-09SEC
2026-09-088-KCurrent report2026-09-03SEC
2026-08-144/A2026-08-06SEC
2026-08-104Statement of changes in beneficial ownership of securities2026-08-06SEC
2026-08-104Statement of changes in beneficial ownership of securities2026-08-06SEC
2026-08-0410-QQuarterly report pursuant to Section 13 or 15(d)2026-06-30SEC
2026-08-048-KCurrent report2026-08-04SEC
2026-07-208-KCurrent report2026-07-19SEC
2026-07-078-KCurrent report2026-07-06SEC
2026-07-064Statement of changes in beneficial ownership of securities2026-07-01SEC
2026-07-028-KCurrent report2026-06-27SEC
2026-07-01144Filing for proposed sale of securities under Rule 144.SEC
2026-06-264Statement of changes in beneficial ownership of securities2026-06-24SEC
2026-06-264Statement of changes in beneficial ownership of securities2026-06-24SEC
2026-06-264Statement of changes in beneficial ownership of securities2026-06-24SEC
2026-06-264Statement of changes in beneficial ownership of securities2026-06-24SEC
2026-06-264Statement of changes in beneficial ownership of securities2026-06-24SEC
2026-06-264Statement of changes in beneficial ownership of securities2026-06-24SEC
2026-06-264Statement of changes in beneficial ownership of securities2026-06-24SEC
2026-06-264Statement of changes in beneficial ownership of securities2026-06-24SEC
2026-06-263Initial statement of beneficial ownership of securities2026-06-18SEC
2026-06-228-KCurrent report2026-06-18SEC

Insider activity by month

MonthBoughtBuysSoldSells
2026-110000
2026-100000
2026-090000
2026-08394.53K300
2026-0700117.71K1
2026-0600113.43K1
2026-050000
2026-040000
2026-0324.35M500
2026-02116.23K200
2026-010000
2025-120047.15K1
2025-110000

Institutional holders

Manager% owned
OEP CAPITAL ADVISORS, L.P.11.99%
BlackRock, Inc.11.81%
DEERFIELD MANAGEMENT COMPANY, L.P.8.44%
FMR LLC7.93%
SkyKnight Capital, L.P.6.31%
REINHART PARTNERS, LLC.5.45%
VANGUARD PORTFOLIO MANAGEMENT LLC4.72%
DIMENSIONAL FUND ADVISORS LP4.69%
VANGUARD CAPITAL MANAGEMENT LLC3.56%
STATE STREET CORP3.41%

Funds

Fund% owned
iShares Core S&P Small-Cap ETF4.78%
Fidelity Value Fund3.56%
VANGUARD TOTAL STOCK MARKET INDEX FUND2.52%
iShares Russell 2000 ETF1.97%
VANGUARD SMALL-CAP INDEX FUND1.83%
U.S. SMALL CAP VALUE PORTFOLIO1.35%
Reinhart Genesis PMV Fund1.33%
Fidelity Advisor Value Strategies Fund1.18%
VANGUARD SMALL-CAP VALUE INDEX FUND1.16%
VANGUARD EXTENDED MARKET INDEX FUND0.90%

OakChart. AHCO. Cached 15 minutes.